Mannosylated liposomes for targeted gene delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1079-1089

  Kong, Fansheng ^a   Zhou, Fang ^a   Ge, Linfu ^a   Liu, Ximin ^a   Wang, Yong ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Active targeting; Gene delivery; Liposomes; Mannosylated; Phosphatidylethanolamine; Polyethylene glycol

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; LIPOSOME; POLYETHYLENE GLYCOL PHOSPHATIDYLETHANOLAMINE; POLYMER; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; MACROGOL DERIVATIVE; MANNOSE; PHOSPHATIDYLETHANOLAMINE;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG DOSAGE FORM COMPARISON; FLOW CYTOMETRY; GENE EXPRESSION; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; LIPOSOMAL GENE DELIVERY SYSTEM; LOADING EFFICIENCY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; POLYDISPERSITY INDEX; RAT; ZETA POTENTIAL; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; KUPFFER CELL; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; GREEN FLUORESCENT PROTEINS; KUPFFER CELLS; LIPOSOMES; MALE; MANNOSE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 84862337350     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29183     Document Type: Article

References (42)

1. Boulaiz H, Marchal JA, Prados J, Melguizo C, Aránega A. Non-viral and viral vectors for gene therapy. Cell Mol Biol (Noisy-le-grand). 2005;51(1):3-22.
2. Zhao XB, Lee RJ. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev. 2004;56(8):1193-1204.
3. Atkinson H, Chalmers R. Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica. 2010;138(5):485-498.
4. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006; 58(14):1532-1555.
5. Li SD, Huang L. Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci. 2006;1082:1-8.
6. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1-16.
7. Béduneau A, Saulnier P, Hindré F, Clavreul A, Leroux JC, Benoit JP. Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials. 2007;28(33): 4978-4990.
8. Yu W, Liu C, Liu Y, Zhang N, Xu W. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 2010;27(8):1584-1596.
9. Yu W, Zhang N. Surface modification of nanocarriers for cancer therapy. Curr Nanosci. 2009;5(2):123-134.
10. Zamboni WC. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res. 2005;11(23):8230-8234.
11. Sun W, Zhang N, Li A, Zou W, Xu W. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm. 2008;353(1-2):243-250.
12. Zhang Q, Cheng SX, Zhang XZ, Zhuo RX. Water soluble polymer protected Lipofectamine 2000/DNA complexes for solid-phase transfection. Macromol Biosci. 2009;9(12):1262-1271.
13. Liu JL, Ma QP, Huang QD, et al. Cationic lipids containing protonated cyclen and different hydrophobic groups linked by uracil-PNA monomer: synthesis and application for gene delivery. Eur J Med Chem. 2011;46(9):4133-4141.
14. Opanasopit P, Paecharoenchai O, Rojanarata T, Ngawhirunpat T, Ruktanonchai U. Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes. Int J Nanomedicine. 2011;6:975-983.
15. Yu W, Zhang N, Li C. Saccharide modified pharmaceutical nanocarriers for targeted drug and gene delivery. Curr Pharm Des. 2009;15(32): 3826-3836.
16. Van Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 2007;24(8):1405-1414.
17. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycoldiacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res. 2002;19(10):1424-1429.
18. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
19. Yang L, Wang L, Su XQ, et al. Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirusencoding endostatin. Cancer Gene Ther. 2010;17(1):49-57.
20. Sawant RM, Hurley JP, Salmaso S, et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem. 2006;17(4):943-949.
21. Reddy JA, Abburi C, Hofland H, et al. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 2002;9(22):1542-1550.
22. Penate Medina O, Haikola M, Tahtinen M, et al. Liposomal tumor targeting in drug delivery utilizing MMP-2-and MMP-9-binding ligands. J Drug Deliv. 2011:160515.
23. Wang SN, Deng YH, Xu H, et al. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. Eur J Pharm Biopharm. 2006;62(1):32-38.
24. Wijagkanalan W, Kawakami S, Takenaga M, et al. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release. 2008;125(2):121-130.
25. Liu C, Chen Z, Yu W, Zhang N. Novel cationic 6-lauroxyhexyl lysinate modified poly (lactic acid)-poly (ethylene glycol) nanoparticles enhance gene transfection. J Colloid Interface Sci. 2011;354(2): 528-535.
26. Adjimatera N, Kral T, Hof M, Blagbrough IS. Lipopolyaminemediated single nanoparticle formation of calf thymus DNA analyzed by fluorescence correlation spectroscopy. Pharm Res. 2006;23(7): 1564-1573.
27. Barre A, Bourne Y, Van Damme EJ, Peumans WJ, Rouge P. Mannosebinding plant lectins: different structural scaffolds for a common sugarrecognition process. Biochimie. 2001;83(7):645-651.
28. Cui ZG, Han SJ, Huang L. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor. Pharm Res. 2004;21(6):1018-1025.
29. Cui Z, Mumper RJ. Topical immunization using nanoengineered genetic vaccines. J Control Release. 2002;81(1-2):173-184.
30. Kong F, Ge L, Liu X, Huang N, Zhou F. Mannan-modified PLGA nanoparticles for targeted gene delivery. Int J Photoenergy. 2011;2012:926754.
31. Olynyk JK, Clarke SL. Isolation and primary culture of rat Kupffer cells. J Gastroenterol Hepatol. 1998;13(8):842-845.
32. Liu H, Cao H, Wu ZY. Isolation of Kupffer cells and their suppressive effects on T lymphocyte growth in rat orthotopic liver transplantation. World J Gastroenterol. 2007;13(22):3133-3136.
33. Gao Y, Gu W, Chen L, Xu Z, Li Y. A multifunctional nano device as non-viral vector for gene delivery: in vitro characteristics and transfection. J Control Release. 2007;118(3):381-388.
34. Managit C, Kawakami S, Yamashita F, Hashida M. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci. 2005;94(10):2266-2275.
35. Yeeprae W, Kawakami S, Yamashita F, Hashida M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release. 2006;114(2): 193-201.
36. Balazs DA, Godbey WT. Liposomes for use in gene delivery. J Drug Deliv. 2011;2011:326497.
37. Summer JB, Howell SF. The identification of the hemagglutinin of the jack bean with concanavalin A. J Bacteriol. 1936;32(2):227-237.
38. Kizhakkedathu JN, Creagh AL, Shenoi RA, et al. High molecular weight polyglycerol-based multivalent mannose conjugates. Biomacromolecules. 2010;11(10):2567-2575.
39. Mangold SL, Cloninger MJ. Binding of monomeric and dimeric concanavalin A to mannose-functionalized dendrimers. Org Biomol Chem. 2006;4(12):2458-2465.
40. Wolfenden ML, Cloninger MJ. Mannose/glucose-functionalized dendrimers to investigate the predictable tunability of multivalent interactions. J Am Chem Soc. 2005;127(35):12168-12169.
41. Yamada M, Nishikawa M, Kawakami S, et al. Tissue and intrahepatic distribution and subcellular localization of a mannosylated lipoplex after intravenous administration in mice. J Control Release. 2004;98(1): 157-167.
42. Kitani H, Takenouchi T, Sato M, Yoshioka M, Yamanaka N. A novel isolation method for macrophage-like cells from mixed primary cultures of adult rat liver cells. J Immunol Methods. 2010;360(1-2):47-55.